Softigel®

Softigel® is a leading Contract Development and Manufacturing organization specializing in softgel advanced technologies for the pharmaceutical and nutraceutical industry. With a focus on innovation, the company aims to bring exceptional experiences to patients and consumers, offering faster market entry for innovative products. Softigel's advanced delivery technologies and regulatory expertise position it as an integrated CDMO (iCDMO) providing full-service, turnkey solutions in prescription drugs, OTC, and dietary supplements. The company's vertical integration and cutting-edge research and development enable it to meet the market demand for superior quality, catering to multinational pharmaceutical companies such as Pfizer, Glaxo, Sanofi, Boehringer Ingelheim, and Bayer. Founded in 1977 and headquartered in Colombia, Softigel has established long-standing relationships with its customers through constant investment in marketing activities and a deep understanding of their portfolios and strategic growth plans. Serving a diverse range of industry-leading customers, including 12 out of the top 20 global multinational pharma companies, Softigel continues to deliver better health and nutrition to patients and consumers worldwide.